The positive correlation between DSN1 expression and TMB, as well as MSI, in a substantial number of cancers suggests that DSN1-high tumors might be more immunogenic, potentially due to increased neoantigen presentation resulting from genomic instability. This evidence concerns the gene DSN1 and cancer.